Curcuminoid supplementation for vasomotor symptoms in postmenopausal women: a pilot, randomized, double-blind, placebo-controlled proof-of-concept trial.
- 2026-03-24
- RCT · n = 40
- BMC complementary medicine and therapies 26(1)
- Jinjutha Buntoonprayuk
- Kitti Chattrakulchai
- Orawin Vallibhakara
- Pimpun Prasanchit
- Sakda Arj-Ong Vallibhakara
- PubMed: 41877056
- DOI: 10.1186/s12906-026-05358-7
- High evidence
- Adults
No statistically significant between-group differences were observed at Week 12 for total MRS II
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 1000 mg/day